<!DOCTYPE html>
<html dir="ltr" lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=5.0">
  <title>Stencil Component Starter</title>

  <script type="module" src="/build/cds-card-viewer.esm.js"></script>
  <script nomodule src="/build/cds-card-viewer.js"></script>

</head>
<body>

  <!--<cds-card
  card='{"summary":"8 Possible Clinical Trials have been found for the Condition: C18 & Subtype: C2852","detail":"The following Research Studies could be considered for the patients condition constellation","indicator":"info","source":{"label":"MOLIT Institute","url":"https://molit.eu/","icon":"https://molit.eu/wp-content/uploads/2017/01/favicon.png"},"suggestions":[{"label":"Human-readable suggestion label","uuid":"e1187895-ad57-4ff7-a1f1-ccf954b2fe46","actions":[{"type":"create","description":"Create a prescription for Acetaminophen 250 MG","resource":{"resourceType":"MedicationRequest"}},{"type":"create","description":"action 2","resource":{"resourceType":"MedicationRequest"}}]},{"label":"Suggestion 2 label","uuid":"e1187895-ad57-4ff7-a1f1-ccf954b2fe46","actions":[{"type":"create","description":"A prescription for something","resource":{"resourceType":"MedicationRequest"}}]}],"selectionBehavior":"at-most-one","links":[{"label":"Adjuvant Aspirin Treatment in PIK3CA Mutated Colon Cancer Patients. A Randomized, Double-blinded, Placebo-controlled, Phase III Trial","url":"https://clinicaltrials.gov/ct2/show/NCT02467582","type":"Clinical Trial","appContext":null},{"label":"Adjuvant Aspirin Treatment in PIK3CA Mutated Colon Cancer Patients. A Randomized, Double-blinded, Placebo-controlled, Phase III Trial","url":"https://clinicaltrials.gov/ct2/show/NCT02467582","type":"Clinical Trial","appContext":null},{"label":"A Phase IIb Study of RAMucirumab in Combination With TAS102 vs. TAS102 Monotherapy in Chemotherapy Refractory Metastatic Colorectal Cancer Patients","url":"https://clinicaltrials.gov/ct2/show/NCT03520946","type":"Clinical Trial","appContext":null},{"label":"A Phase 1b/2 Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors","url":"https://clinicaltrials.gov/ct2/show/NCT03184870","type":"Clinical Trial","appContext":null},{"label":"Adjuvant Aspirin Treatment in PIK3CA Mutated Colon Cancer Patients. A Randomized, Double-blinded, Placebo-controlled, Phase III Trial","url":"https://clinicaltrials.gov/ct2/show/NCT02467582","type":"Clinical Trial","appContext":null},{"label":"A Phase 1b/2 Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors","url":"https://clinicaltrials.gov/ct2/show/NCT03184870","type":"Clinical Trial","appContext":null},{"label":"Adjuvant Aspirin Treatment in PIK3CA Mutated Colon Cancer Patients. A Randomized, Double-blinded, Placebo-controlled, Phase III Trial","url":"https://clinicaltrials.gov/ct2/show/NCT02467582","type":"Clinical Trial","appContext":null},{"label":"A Phase IIb Study of RAMucirumab in Combination With TAS102 vs. TAS102 Monotherapy in Chemotherapy Refractory Metastatic Colorectal Cancer Patients","url":"https://clinicaltrials.gov/ct2/show/NCT03520946","type":"Clinical Trial","appContext":null}]}'
  show-suggestion-actions="true"
  ></cds-card> -->

  <cds-card card='{"summary":"No Studies can be suggested.","detail":"No subtype found for patient","indicator":"critical","source":null,"suggestions":null,"selectionBehavior":null,"links":null}' />

</body>
</html>
